Victoza® provides significantly greater blood sugar reduction than lixisenatide in new clinical trial

Findings from a head-to-head trial have demonstrated a significantly greater reduction in blood sugar for liraglutide compared to lixisenatide in adults with type 2 diabetes

Source: Pharmacy Europe - September 16, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Clinical trials Practical therapeutics Diabetes Patient care Research blood sugar EASD Latest News LIRA-LIXI trial liraglutide lixisenatide type 2 diabetes victoza Source Type: news